Bml Capital Management, LLC Incresed Positions in Q3 2024

Bml Capital Management, LLC

  • $170 Billion
  • Q3 2024
Stock Shares change Price Range Shares Held Trade History
ACHL
Achilles Therapeutics PLC

Healthcare
3.47M
+ 555.82%
$0.7 - $1.04 $2.43M - $3.61M
4.1M $4.18B
Adverum Biotechnologies Inc
302K
+ 15.36%
N/A
2.27M $15.9B
ACRS
Aclaris Therapeutics, Inc.

Healthcare
1.26M
+ 9.72%
$1.12 - $1.4 $1.41M - $1.77M
14.3M $16.4B
ORMP
Oramed Pharmaceuticals Inc.

Healthcare
837K
+ 62.06%
$2.21 - $2.63 $1.85M - $2.2M
2.19M $5.33B
RPHM
Reneo Pharmaceuticals, Inc.

Healthcare
785K
+ 29.38%
$1.34 - $1.7 $1.05M - $1.33M
3.46M $5.88B
AVIR
Atea Pharmaceuticals, Inc.

Healthcare
274K
+ 4.3%
$3.17 - $4.02 $870K - $1.1M
6.65M $22.3B
PMVP
Pmv Pharmaceuticals, Inc.

Healthcare
379K
+ 28.97%
$1.44 - $1.69 $546K - $641K
1.69M $2.52B
IKNA
Ikena Oncology, Inc.

Healthcare
138K
+ 23.61%
$1.6 - $1.85 $221K - $256K
723K $1.25B
MIST
Milestone Pharmaceuticals Inc.

Healthcare
33.2K
+ 3.01%
$1.29 - $1.65 $42.8K - $54.8K
1.14M $1.73B
Talis Biomedical Corp
206K
+ 481.85%
N/A
249K $460M
Activity Summary
Buys All Purchases 16 New Holdings 5 Increased Positions 11 Sells All Sells 6 Reductions 6 Sold out 0 Options Calls 0 Puts 0
Track This Portfolio

Track Bml Capital Management, LLC Portfolio

Follow Bml Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bml Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email